The Audio Journal of Oncology tracks down the half dozen leading stories breaking in Turin at ESTRO 2016—the annual meeting of the European Society for Radiotherapy and Oncology. Nicolle Rekers MSc., Maastricht University, Netherlands discusses the “Abscopal Effect” in which the potency of a new immunotherapy was enhanced within and beyond the field of co-administered radiation.
You may also like...
PSA-membrane antibody conjugate shows promise for treating metastatic castration-resistant, taxane-refractory prostate cancer 6 Feb, 2014 Long Overall Survival in Ceritinib-Treated ALK-Positive Lung Cancer 27 Oct, 2018 Audio Journal of Oncology Volume 16 Number 11 3 Jun, 2008 Lowering hematocrit below 45 per cent protects against clotting risk in patients with polycythemia vera — randomized study finding 11 Dec, 2012
- Previous story ‘Rescanning’ Optimizes Pencil Beam Proton Delivery to Moving Lung Tumor
- Next story Can these Women with Breast Cancer Avoid Chemotherapy?
- Ultrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
- First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
- Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
- Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
- MMR vaccine’s non-specific effects: adherence to recommended vaccination schedules protects children against non-vaccination-specific infections tooFebruary 28, 2014